Male breast cancer is driven primarily by an imbalance between estrogen and testosterone, with estrogen promoting the growth of breast tissue that can become cancerous. About 0.1% of men will develop breast cancer by age 70, and the average age at diagnosis is 71. While rare, the causes are well understood, and most fall into a few key categories: hormonal shifts, inherited gene changes, body composition, and prior medical treatments.
How Hormones Drive Male Breast Cancer
Men have breast tissue, and that tissue contains receptors for estrogen, testosterone, and progesterone. Normally, testosterone keeps estrogen in check by blocking estrogen’s ability to activate those receptors and trigger cell growth. When that balance tips toward estrogen, breast cells can begin to multiply in ways that eventually become cancerous.
Estrogen stimulates the growth of breast ducts, while testosterone actively opposes that effect. Any condition, medication, or body change that raises estrogen levels or lowers testosterone can create an environment where breast tissue proliferates unchecked. This hormonal mechanism is the common thread connecting nearly every known risk factor for male breast cancer.
Inherited Gene Changes
The most significant genetic risk comes from inherited changes in the BRCA1 and BRCA2 genes. According to the National Cancer Institute, men who carry a harmful BRCA2 change have a 1.8% to 7.1% chance of developing breast cancer by age 70. That’s roughly 18 to 71 times the risk of the general male population. BRCA1 carriers face a smaller but still elevated risk of 0.2% to 1.2% by age 70.
Men with a family history of breast cancer in either male or female relatives, or a family history of ovarian, pancreatic, testicular, or prostate cancers, may carry one of these gene changes without knowing it. Genetic counseling is generally recommended for men over 35 who have this kind of family history.
Klinefelter Syndrome
Men born with an extra X chromosome (a condition called Klinefelter syndrome) face a dramatically higher risk. The most convincing data suggest a 20- to 30-fold increase in breast cancer risk compared to men with typical chromosomes. One Swedish study that systematically tested 93 men with breast cancer found that 7.5% of them had Klinefelter syndrome, a rate far higher than you’d expect by chance.
Klinefelter syndrome causes the body to produce less testosterone and more estrogen, which directly feeds the hormonal imbalance that promotes breast cancer. Roughly 7 out of 10 men with the condition are never diagnosed, meaning many are unaware they carry this risk.
Body Weight and Estrogen Production
Fat tissue doesn’t just store energy. It contains an enzyme called aromatase that actively converts testosterone into estrogen. In men with obesity, this creates a feedback loop: more fat tissue means more estrogen production, and that extra estrogen also suppresses the hormonal signals that tell the body to make testosterone. The result is both higher estrogen and lower testosterone at the same time.
Obese men produce up to twice as much estrogen as men at an average weight, and men with a BMI of 35 or higher show markedly decreased testosterone alongside elevated estrogen in their blood. A large pooled analysis of more than 2,400 patients from 10 studies found that obesity increased male breast cancer risk by about 30%. The hormonal environment created by excess fat tissue closely mirrors the conditions that encourage tumor development in breast tissue.
Liver Disease
The liver is responsible for breaking down estrogen in the body. When the liver is damaged by cirrhosis, it can no longer clear estrogen efficiently, leading to a buildup that shifts the hormonal balance. A Danish study followed more than 11,600 men with liver cirrhosis and found they developed breast cancer at roughly four times the expected rate. Cirrhosis from any cause, whether alcohol-related, viral hepatitis, or other conditions, can produce this effect.
Prior Chest Radiation
Men who received radiation therapy to the chest earlier in life, often as treatment for another cancer like lymphoma, have a higher risk of developing breast cancer later. Radiation damages DNA in breast tissue cells, and over years or decades, those mutations can accumulate and lead to cancer. The risk is specific to radiation directed at the chest area, not radiation treatment to other parts of the body.
Estrogen-Based Medications
Drugs containing estrogen that were historically used to treat prostate cancer increased male breast cancer risk by directly flooding the body with the hormone that drives breast cell growth. While estrogen-based prostate cancer treatments are far less common today, men who received them in the past still carry that elevated risk. Any medication or supplement that significantly raises estrogen levels could theoretically have a similar effect.
Age Is the Most Common Risk Factor
The majority of men diagnosed with breast cancer have no identifiable risk factor other than age. The average diagnosis comes at 71, and the risk climbs steadily after 50. This is partly because testosterone naturally declines with age while estrogen levels remain more stable, gradually tilting the hormonal balance. It’s also because cancer-causing mutations accumulate in cells over a lifetime.
Because the disease is so rare, routine screening for men doesn’t exist. But any man over 50 who notices a lump, thickening, or change in the breast or nipple area should have it evaluated. Most breast lumps in men turn out to be gynecomastia, a benign enlargement of breast tissue that shows up as a firm, disc-shaped area centered behind the nipple. Cancerous lumps tend to be off-center, painless, and fixed to the skin or underlying tissue rather than freely movable. The distinction matters, because catching male breast cancer early dramatically improves outcomes.